Search

everythinglearnresearchcommunity

for

Search:↓

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

More research is needed to understand and treat morphea effectively.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

COVID-19 infection may trigger alopecia areata in some patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Apremilast did not work for treating severe alopecia areata.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

ILC1-like cells can independently cause alopecia areata.

Different treatments for alopecia areata have unpredictable results and varying success rates.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.